Ammon HP and Wahl MA: Pharmacology of Curcuma longa. Planta Med. 57:1–7. 1991. View Article : Google Scholar : PubMed/NCBI

Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN and Kuttan R: Antitumor and oxidant activity of natural curcuminoids. Cancer Lett. 94:79–83. 1995. View Article : Google Scholar : PubMed/NCBI

Apisariyakul A, Vanittanakom N and Buddhasukh D: Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol. 49:163–169. 1995. View Article : Google Scholar : PubMed/NCBI

Asher GN, Corbett AH and Hawke RL: Common herbal dietary supplement-drug interactions. Am Fam Physician. 96:101–107. 2017.PubMed/NCBI

Ammon HP, Safayhi H, Mack T and Sabieraj J: Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol. 38:113–119. 1993. View Article : Google Scholar : PubMed/NCBI

Akram M, Shahab-Uddin, Afzal A, Khan U, Abdul H, Mohiuddin E and Asif M: Curcuma longa and curcumin: A review article. Rom J Biol Plant Biol. 55:65–70. 2010.

Chainani-Wu N: Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med. 1:161–168. 2003. View Article : Google Scholar

Singh S and Kher A: Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem. 6:259–270. 2006. View Article : Google Scholar : PubMed/NCBI

Rahmani AH, Al Zohairy MA, Aly SM and Khan MA: Curcumin: A potential candidate in prevention of cancer via modulation of molecular pathways. Biomed Res Int. 2014:7616082014. View Article : Google Scholar : PubMed/NCBI

Maheshwari RK, Singh AK, Gaddipati J and Srimal RC: Multiple biological activities of curcumin: A short review. Life Sci. 78:2081–2087. 2006. View Article : Google Scholar : PubMed/NCBI

Zhang M, Bian F, Wen C and Hao N: Inhibitory effect of curcumin on proliferation of human pterygium fibroblasts. J Huazhong Univ Sci Technolog Med Sci. 27:339–342. 2007. View Article : Google Scholar : PubMed/NCBI

Huynh TP, Mann SN and Mandal NA: Botanical compounds: Effects on major eye diseases. Evid Based Complement Alternat Med. 2013:5491742013. View Article : Google Scholar : PubMed/NCBI

Sancilio S, Di Staso S, Sebastiani S, Centurione L, Di Girolamo N, Ciancaglini M and Di Pietro R: Curcuma longa is able to induce apoptotic cell death of pterygium-derived human keratinocytes. Biomed Res Int. 2017:29565972017. View Article : Google Scholar

Sudhalkar A: Fixation and its role in the causation, laterality and location of pterygium: A study in amblyopes and non-amblyopes. Eye (Lond). 26:438–443. 2012. View Article : Google Scholar

Livezeanu C, Crăiţoiu MM, Mănescu R, Mocanu C and Crăiţoiu S: Angiogenesis in the pathogenesis of pterygium. Rom J Morphol Embryol. 52:837–844. 2011.PubMed/NCBI

Dos Reis GM, de P R Júnior A, E Silva KS, Rodrigues DA, Gomes MC, Martins JV, da Costa IR, Freitas GA and Moura KK: Pterygium in patients from Goiânia, Goiás, Brazil. Genet Mol Res. 14:6182–6188. 2015. View Article : Google Scholar : PubMed/NCBI

Lu CW, Hao JL, Yao L, Li HJ and Zhou DD: Efficacy of curcumin in inducing apoptosis and inhibiting the expression of VEGF in human pterygium fibroblasts. Int J Mol Med. 39:1149–1154. 2017. View Article : Google Scholar : PubMed/NCBI

Mauro J and Foster CS: Pterygia: Pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol. 24:130–134. 2009. View Article : Google Scholar : PubMed/NCBI

Ribatti D, Nico B, Perra MT, Maxia C, Piras F, Murtas D, Crivellato E and Sirigu P: Correlation between NGF/TrkA and microvascular density in human pterygium. Int J Exp Pathol. 90:615–620. 2009. View Article : Google Scholar : PubMed/NCBI

Clearfield E, Muthappan V, Wang X and Kuo IC: Conjunctival autograft for pterygium. Cochrane Database Syst Rev. 2:CD0113492016.PubMed/NCBI

Hacıoğlu D and Erdöl H: Developments and current approaches in the treatment of pterygium. Int Ophthalmol. 37:1073–1081. 2017. View Article : Google Scholar

Hirst LW: The treatment of pterygium. Surv Ophthalmol. 48:145–180. 2003. View Article : Google Scholar : PubMed/NCBI

Nuzzi R and Tridico F: How to minimize pterygium recurrence rates: Clinical perspectives. Clin Ophthalmol. 12:2347–2362. 2018. View Article : Google Scholar : PubMed/NCBI

Fries FN, Suffo S, Daas L, Seitz B, Fiorentzis M and Viestenz A: Tenonplasty for closing defects during sclerocorneal surgery-A brief review of its anatomy and clinical applications. Clin Anat. 31:72–76. 2018. View Article : Google Scholar

Jirásková N and Rozsíval P: Treatment for recurrent pterygium. Cesk Slov Oftalmol. 64:68–70. 2008.In Czech.

Chu WK, Choi HL, Bhat AK and Jhanji V: Pterygium: New insights. Eye (Lond). 34:1047–1050. 2020. View Article : Google Scholar

Yanyali AC, Talu H, Alp BN, Karabas L, Ay GM and Caglar Y: Intraoperative mitomycin C in the treatment of pterygium. Cornea. 19:471–473. 2000. View Article : Google Scholar : PubMed/NCBI

Guo Q, Li X, Cui MN, Liang Y, Li XP, Zhao J, Wei LN, Zhang XL and Quan XH: Low-dose Mitomycin C decreases the postoperative recurrence rate of pterygium by perturbing NLRP3 inflammatory signalling pathway and suppressing the expression of inflammatory factors. J Ophthalmol. 2019:94727822019. View Article : Google Scholar : PubMed/NCBI

Hickey-Dwyer M and Wishart PK: Serious corneal complication of 5-fluorouracil. Br J Ophthalmol. 77:250–251. 1993. View Article : Google Scholar : PubMed/NCBI

Nosratzehi T, Arbabi-Kalati F, Hamishehkar H and Bagheri S: Comparison of the effects of curcumin mucoadhesive paste and local corticosteroid on the treatment of erosive oral lichen planus lesions. J Natl Med Assoc. 110:92–97. 2018. View Article : Google Scholar : PubMed/NCBI

Shishodia S, Singh T and Chaturvedi MM: Modulation of transcription factors by curcumin. Adv Exp Med Biol. 595:127–148. 2007. View Article : Google Scholar : PubMed/NCBI

Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD and Conney AH: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:813–819. 1991.PubMed/NCBI

Zhang F, Altorki NK, Mestre JR, Subbaramaiah K and Dannenberg AJ: Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 20:445–451. 1999. View Article : Google Scholar : PubMed/NCBI

Bundy R, Walker AF, Middleton RW and Booth J: Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study. J Altern Complement Med. 10:1015–1018. 2004. View Article : Google Scholar

Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK and Lee SS: Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 480-481:243–268. 2001. View Article : Google Scholar : PubMed/NCBI

Cheng Y, Ping J and Liu C: Effect of curcumin on activity of matrix metalloproteinase 2, 9 and nuclear expression of RelA in rat hepatic stellate cells by activating peroxisome proliferator-activated receptor gamma signal. Zhongguo Zhong Xi Yi Jie He Za Zhi. 27:439–443. 2007.In Chinese. PubMed/NCBI

McCawley LJ and Matrisian LM: Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol. 13:534–540. 2001. View Article : Google Scholar : PubMed/NCBI

Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P and Srimal RC: Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 13:318–322. 1999. View Article : Google Scholar : PubMed/NCBI

Allegri P, Mastromarino A and Neri P: Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol. 4:1201–1206. 2010.PubMed/NCBI

Vallée A and Lecarpentier Y: Curcumin and endometriosis. Int J Mol Sci. 21:24402020. View Article : Google Scholar :

Liu JY, Lin SJ and Lin JK: Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis. 14:857–861. 1993. View Article : Google Scholar : PubMed/NCBI

Kuo ML, Huang TS and Lin JK: Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta. 1317:95–100. 1996. View Article : Google Scholar : PubMed/NCBI

Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, Min DS, Chang JS, Jeong YJ, Lee YH, et al: Molecular mechanisms of curcumin-induced cytotoxicity: Induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 24:1199–1208. 2003. View Article : Google Scholar : PubMed/NCBI

Bhaumik S, Anjum R, Rangaraj N, Pardhasaradhi BV and Khar A: Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett. 456:311–314. 1999. View Article : Google Scholar : PubMed/NCBI

Fang J, Lu J and Holmgren A: Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity. J Biol Chem. 280:25284–25290. 2005. View Article : Google Scholar : PubMed/NCBI

Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol. 69:195–206. 2006. View Article : Google Scholar

Lękawa-Ilczuk A, Antosz H, Rymgayłło-Jankowska B and Zarnowski T: Expression of double strand DNA breaks repair genes in pterygium. Ophthalmic Genet. 32:39–47. 2001. View Article : Google Scholar

Kau HC, Tsai CC, Lee CF, Kao SC, Hsu WM, Liu JH and Wei YH: Increased oxidative DNA damage, 8-hydroxydeoxy-guanosine, in human pterygium. Eye (Lond). 20:826–831. 2006. View Article : Google Scholar

Henning RJ: Therapeutic angiogenesis: Angiogenic growth factors for ischemic heart disease. Future Cardiol. 12:585–599. 2016. View Article : Google Scholar : PubMed/NCBI

Folkman J and Klagsbrun M: Angiogenetic factors. Science. 235:442–447. 1987. View Article : Google Scholar : PubMed/NCBI

Liu W, Sha X, Wen Y, Zhao W, Luo W and Hua Z: Effect of Avastin on the migration and invasion of pterygium fibroblasts. Eye Sci. 29:214–218. 2014.

Zhang J, Cao YJ, Li FY, Li J, Yao LB and Duan EK: Effects of fibronectin, VEGF and angiostatin on the expression of MMPs through different signaling pathways in the JEG-3 cells. Am J Reprod Immunol. 50:273–285. 2003. View Article : Google Scholar : PubMed/NCBI

Liacini A, Sylvester J, Li WQ and Zafarullah M: Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articulate chondrocytes. Matrix Biol. 21:251–262. 2002. View Article : Google Scholar : PubMed/NCBI

Kim SJ, Choi JS and Chung SK: The effect of curcumin on corneal neovascularization in rabbit eyes. Curr Eye Res. 35:274–280. 2010. View Article : Google Scholar : PubMed/NCBI

Sarayba MA, Li L, Tungsiripat T, Liu NH, Sweet PM, Patel AJ, Osann KE, Chittiboyina A, Benson SC, Pershadsingh HA and Chuck RS: Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. Exp Eye Res. 80:435–442. 2005. View Article : Google Scholar : PubMed/NCBI

Sun ZJ, Chen G, Zhang W, Hu X, Liu Y, Zhou Q, Zhu LX and Zhao YF: Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-κB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex signaling axis in adenoid cystic carcinoma. Mol Pharmacol. 79:106–118. 2011. View Article : Google Scholar

Araki-Sasaki K, Katsuta O, Mano H, Nagano T and Nakamura M: The effects of oral and topical corticosteroid in rabbit corneas. BMC Ophthalmol. 16:1602016. View Article : Google Scholar : PubMed/NCBI

Azimzade Y, Hong J and Mashaghi A: Immunophysical analysis of corneal neovascularization: Mechanistic insights and implications for pharmacotherapy. Sci Rep. 7:122202017. View Article : Google Scholar : PubMed/NCBI

Zemanová M and Matušková V: Benefits and negatives of corticosteroid therapy in corneal pathologies. Cesk Slov Oftalmol. 73:69–77. 2017.

Dahmana N, Mugnier T, Gabriel D, Kaltsatos V, Bertaim T, Behar-Cohen F, Gurny R and Kalia YN: Topical admin-istration of spironolactone-loaded nanomicelles prevents glucocorticoid-induced delayed corneal wound healing in rabbits. Mol Pharm. 15:1192–1202. 2018. View Article : Google Scholar : PubMed/NCBI

Stepp MA, Zieske JD, Trinkaus-Randall V, Kyne BM, Pal-Ghosh S, Tadvalkar G and Pajoohesh-Ganji A: Wounding the cornea to learn how it heals. Exp Eye Res. 121:178–193. 2014. View Article : Google Scholar : PubMed/NCBI

Petroutsos G, Guimaraes R, Giraud JP and Pouliquen Y: Corticosteroids and corneal epithelial wound healing. Br J Ophthalmol. 66:705–708. 1982. View Article : Google Scholar : PubMed/NCBI

Kadmiel M, Janoshazi A, Xu X and Cidlowski JA: Glucocorticoid action in human corneal epithelial cells establishes roles for corticosteroids in wound healing and barrier function of the eye. Exp Eye Res. 152:10–33. 2016. View Article : Google Scholar : PubMed/NCBI

Kotha RR and Luthria DL: Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. 24:29302019. View Article : Google Scholar :

Mehra KS, Mikuni I, Gupta U and Gode KD: Curcuma longa (Linn) drops in corneal wound healing. Tokai J Exp Clin Med. 9:27–31. 1984.PubMed/NCBI

Wu Y, Qin D, Yang H and Fu H: Evidence for the participation of acid-sensing ion channels (ASICs) in the antinociceptive effect of curcumin in a formalin-induced orofacial inflammatory model. Cell Mol Neurobiol. 37:635–642. 2017. View Article : Google Scholar

Enyeart JA, Liu H and Enyeart JJ: Curcumin inhibits bTREK-1 K⁺ channels and stimulates cortisol secretion from adrenocortical cells. Biochem Biophys Res Commun. 370:623–628. 2008. View Article : Google Scholar : PubMed/NCBI

Guo C, Li M, Qi X, Lin G, Cui F, Li F and Wu X: Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice. Sci Rep. 6:297532016. View Article : Google Scholar : PubMed/NCBI

Panchatcharam M, Miriyala S, Gayathri VS and Suguna L: Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol Cell Biochem. 290:87–96. 2006. View Article : Google Scholar : PubMed/NCBI

Dai X, Liu J, Zheng H, Wichmann J, Hopfner U, Sudhop S, Prein C, Shen Y, Günther H and Schilling A: Nano-formulated curcumin accelerates acute wound healing through Dkk-1-mediated fibro-blast mobilization and MCP-1-mediated anti-inflammation. NPG Asia Mat. 9:e3682017. View Article : Google Scholar

Beltrani VS, Barsanti FA and Bielory L: Effects of glucocor-ticosteroids on the skin and eye. Immunol Allergy Clin North Am. 25:557–580. 2005. View Article : Google Scholar : PubMed/NCBI

Mehra KS, Mikuni I and Kumar A: Effects of vit: A and cortisone on healing of corneal superficial wounds. Tokai J Exp Clin Med. 7:315–318. 1982.PubMed/NCBI

Yamada M and Mashima Y: Changes in proliferation and differentiation of basal cells during wound healing of rabbit corneal epithelial abrasions. Nippon Ganka Gakkai Zasshi. 99:10–16. 1995.In Japanese. PubMed/NCBI

Sridhar MS: Anatomy of cornea and ocular surface. Indian J Ophthalmol. 66:190–194. 2018.PubMed/NCBI

Ehlers N, Heegaard S, Hjortdal J, Ivarsen A, Nielsen K and Prause JU: Morphological evaluation of normal human corneal epithelium. Acta Ophthalmol. 88:858–861. 2010. View Article : Google Scholar : PubMed/NCBI

Del Monte DW and Kim T: Anatomy and physiology of the cornea. J Cataract Refract Surg. 37:588–598. 2011. View Article : Google Scholar

Hassell JR and Birk DE: The molecular basis of corneal transparency. Exp Eye Res. 91:326–335. 2010. View Article : Google Scholar : PubMed/NCBI

Wilson SL, El Haj AJ and Yang Y: Control of scar tissue formation in the cornea: Strategies in clinical and corneal tissue engineering. J Funct Biomater. 3:642–687. 2012. View Article : Google Scholar : PubMed/NCBI

Liu XF, Hao JL, Xie T, Mukhtar NJ, Zhang W, Malik TH, Lu CW and Zhou DD: Curcumin, a potential therapeutic candidate for anterior segment eye diseases: A review. Front Pharmacol. 8:662017.PubMed/NCBI

Yu FS, Yin J, Xu K and Huang J: Growth factors and corneal epithelial wound healing. Brain Res Bull. 81:229–235. 2010. View Article : Google Scholar :

Georgakopoulos CD, Makri OE, Pagoulatos D and Karamanos NK: Expression and localization of glycosamino-glycans/proteoglycan in pterygium: An immunohistochemical study. Med Hypothesis Discov Innov Ophthalmol. 8:39–43. 2019.PubMed/NCBI

Hayashi R, Ishikawa Y, Sasamoto Y, Katori R, Nomura N, Ichikawa T, Araki S, Soma T, Kawasaki S, Sekiguchi K, et al: Co-ordinated ocular development from human iPS cells and recovery of corneal function. Nature. 531:376–380. 2016. View Article : Google Scholar : PubMed/NCBI

Hackam DJ and Ford HR: Cellular, biochemical, and clinical aspects of wound healing. Surg Infect (Larchmt). 3(Suppl 1): S23–S35. 2002. View Article : Google Scholar

Deljou A, Weingarten TN, Mahr MA, Sprung J and Martin DP: Postoperative corneal injuries: Incidence and risk factors. Anesth Analg. 129:737–742. 2019. View Article : Google Scholar : PubMed/NCBI

Nita M and Grzybowski A: The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid Med Cell Longev. 2016:31647342016. View Article : Google Scholar : PubMed/NCBI

Reinstein DZ, Archer TJ and Randleman JB: Mathematical model to compare the relative tensile strength of the cornea after PRK, LASIK, and small incision lenticule extraction. J Refract Surg. 29:454–460. 2013. View Article : Google Scholar : PubMed/NCBI

Nedelec B, Shankowsky H, Scott PG, Ghahary A and Tredget EE: Myofibroblasts and apoptosis in human hypertrophic scars: The effect of interferon-alpha2b. Surgery. 130:798–808. 2001. View Article : Google Scholar : PubMed/NCBI

Meyer JC, Stulting RD, Thompson KP and Durrie DS: Late onset of corneal scar after excimer laser photorefractive keratectomy. Am J Ophthalmol. 121:529–539. 1996. View Article : Google Scholar : PubMed/NCBI

Sarchahi AA, Parizi AM, Eghtedar M and Keshavarz S: Effect of different treatment regimen with dexamethasone and acetyl-cysteine on corneal wound healing in rabbits. Iran J Med Sci. 36:188–195. 2001.

Amon M and Busin M: Loteprednol etabonate ophthalmic suspension 0.5%: Efficacy and safety for postoperative anti-inflammatory use. Int Ophthalmol. 32:507–517. 2012. View Article : Google Scholar : PubMed/NCBI

Csorba A, Soproni A, Maneschg O, Nagy ZZ and Szamosi A: Application of corticosteroid eye drops for allergic eye diseases in children. Orv Hetil. 160:329–337. 2019. View Article : Google Scholar : PubMed/NCBI

Ramamoorthy S and Cidlowski JA: Corticosteroids: Mechanisms of action in health and disease. Rheum Dis Clin North Am. 42:15–31. vii2016. View Article : Google Scholar

Cronstein BN, Kimmel SC, Levin RI, Martiniuk F and Weissmann G: A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA. 89:9991–9995. 1992. View Article : Google Scholar : PubMed/NCBI

Jagetia GC and Rajanikant GK: Role of curcumin, a naturally occurring phenolic compound of turmeric in accelerating the repair of excision wound, in mice whole-body exposed to various doses of gamma-radiation. J Surg Res. 120:127–138. 2004. View Article : Google Scholar : PubMed/NCBI

Ahmad A and Ahsan H: Biomarkers of inflammation and oxidative stress in ophthalmic disorders. J Immunoassay Immunochem. 41:257–271. 2020. View Article : Google Scholar : PubMed/NCBI

Amir Aslani B and Ghobadi S: Studies on oxidants and anti-oxidants with a brief glance at their relevance to the immune system. Life Sci. 146:163–173. 2016. View Article : Google Scholar : PubMed/NCBI

Kant V, Gopal A, Pathak NN, Kumar P, Tandan SK and Kumar D: Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats. Int Immunopharmacol. 20:322–330. 2014. View Article : Google Scholar : PubMed/NCBI

Yen YH, Pu CM, Liu CW, Chen YC, Chen YC, Liang CJ, Hsieh JH, Huang HF and Chen YL: Curcumin accelerates cutaneous wound healing via multiple biological actions: The involvement of TNF-α, MMP-9, α-SMA, and collagen. Int Wound J. 15:605–617. 2018. View Article : Google Scholar : PubMed/NCBI

Ravindranath V and Chandrasekhara N: Metabolism of curcumin- studies with [3H] curcumin. Toxicology. 22:337–344. 1981. View Article : Google Scholar : PubMed/NCBI

Ramsewak RS, DeWitt DL and Nair MG: Cytotoxicity, anti-oxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine. 7:303–308. 2000. View Article : Google Scholar : PubMed/NCBI

Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, et al: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21:2895–2900. 2001.PubMed/NCBI

Anand P, Kunnumakkara AB, Newman RA and Aggarwal BB: Bioavailability of curcumin: Problems and promises. Mol Pharm. 4:807–818. 2007. View Article : Google Scholar : PubMed/NCBI

Feng T, Wei Y, Lee RJ and Zhao L: Liposomal curcumin and its application in cancer. Int J Nanomedicine. 12:6027–6044. 2017. View Article : Google Scholar : PubMed/NCBI

Lee DY, Hou YC, Yang JS, Lin HY, Chang TY, Lee KH, Kuo SC and Hsieh MT: Synthesis, anticancer activity, and preliminary pharmacokinetic evaluation of 4,4-disubstituted curcuminoid 2,2-bis(Hydroxymethyl)Propionate derivatives. Molecules. 25:4792020. View Article : Google Scholar :

Lin X, Shi Y, Yu S, Li S, Li W, Li M, Chen S, Wang Y and Cong M: Preparation of poloxamer188-b-PCL and study on in vitro radioprotection activity of curcumin-loaded nanoparticles. Front Chem. 8:2122020. View Article : Google Scholar :

Joseph M, Trinh HM, Cholkar K, Pal D and Mitra AK: Recent perspectives on the delivery of biologics to back of the eye. Expert Opin Drug Deliv. 14:631–645. 2017. View Article : Google Scholar :